Phosphatidylcholine functional foods and nutraceuticals: A potential approach to prevent non-alcoholic fatty liver disease

European Journal of Lipid Science and Technology

Volumn 114, Issue 4, 2012, Pages 389-398

  Duric, Maida ^a   Sivanesan, Sugas ^a   Bakovic, Marica ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

Betaine; Choline; CVD; NAFLD; Phosphatidylcholine

Indexed keywords

ANIMALIA;

EID: 84859597527     PISSN: 14387697     EISSN: 14389312     Source Type: Journal    
DOI: 10.1002/ejlt.201100350     Document Type: Review

References (88)

1. Pischke, C. R., Weidner, G., Elliott-Eller, M. Scherwitz, L. et al., Comparison of coronary risk factors and quality of life in coronary artery disease patients with versus without diabetes mellitus. Am. J. Cardiol. 2006, 97, 1267- 1273.
2. Knowler, W. C., Barrett-Connor, E., Fowler, S. E., Hamman, R. F. et al., Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. Diabetes Prevention Program Research Group. N. Engl. J. Med. 2002, 346, 393- 403.
3. Keller, K. B., Lemberg, L., Obesity and the metabolic syndrome. Am. J. Crit. Care 2003, 12, 167- 170.
4. World Health Organization, The Atlas of Heart Disease and Stroke, WHO Publications Center, WHO Press, Geneva 2004.
5. Mezey, E., Liver disease and nutrition. Gastroenterology 1978, 74, 770- 783.
6. Ioannou, G., Weiss, N., Boyko, E., Mozaffarian, D., Lee, S., Elevated serum alanine aminotransferase activity and calculated risk of coronary heart disease in the United States. Hepatology 2006, 43, 1145- 1151.
7. Gibney, M. J., Vorster, H. H., Kok, F. J., Introduction to Human Nutrition Edited on behalf of The Nutrition Society, Blackwell Publishing West Sussex, UK 2002.
8. Lam, B., Younossi, Z. M., Treatment options for non-alcoholic liver disease. Ther. Adv. Gastroenterol. 2010, 3, 121- 137.
9. Angulo, P., Nonalcoholic fatty liver disease. N. Engl. J. Med. 2002, 346, 1221- 1231.
10. Bedogni, G., Miglioli, L., Masutti, F., Castiglione, A. et al., Incidence and natural course of fatty liver in the general population: The Dionysos Study. Hepatology 2007, 46, 1387- 1391.
11. Roberts, E. A., Non-alcoholic fatty liver disease (NAFLD) in children. Front. Biosci. 2005, 10, 2306- 2318.
12. Torres, D. M., Harrisson, S. A., Diagnosis and therapy of nonalcoholic steatohepatitis. Gastroenterology 2008, 134, 1682- 1998.
13. Diab, D. L., Yerian, L., Schauer, P., Kashyap, S. R. et al., Cytokeratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients. Clin. Gastroenterol. Hepatol. 2008, 6, 1249- 1254.
14. Zeisel, S. H., Choline-gene interactions: A model for study of the nutrigenetic effects of functional foods on brain development. Funct. Food Rev. 2010, 2, 101- 108.
15. Zeisel, S. H., Nutritional importance of choline for brain development. J. Am. Coll. Nutr. 2004, 23, 621S- 626S.
16. Zeisel, S. H., Choline: An essential nutrient for humans. Nutrition 2000, 16, 669- 671.
17. Sakamoto, A., Nishimura, Y., Ono, H., Sakura, N., Betaine and homocysteine concentrations in foods. Pediatr. Int. 2002, 44, 409- 413.
18. 12, Pantothenic Acid, Biotin, and Choline, National Academic Press, Washington DC 1998, pp. 390- 422.
19. Jensen, H. H., Batres-Marquez, S. P., Carriquiry, A., Schalinske, K. L., Choline in the diets of the U.S. population: NHANES, 2003-2004. FASEB J. 2007, 21, lb219.
20. Craig, S. A., Betaine in human nutrition. Am. J. Clin. Nutr. 2004, 80, 539- 549.
21. Kathirvel, E., Morgan, K., Nandgiri, G., Sandoval, B. C. et al., Betaine improves nonalcoholic fatty liver and associated hepatic insulin resistance: A potential mechanism for hepatoprotection by betaine. Am. J. Physiol. Gastrointest Liver Physiol. 2010, 299, G1068- G1077.
22. Best, C. H., Ferguson, G. C., Hershey, J. M., Choline and liver fat in diabetic dogs. J. Physiol. 1933, 79, 94- 102.
23. Best, C. H., Huntsman, M. E., The effects of the components of lecithine upon digestion of fat in the liver. J. Physiol. 1932, 75, 405- 412.
24. Griffith, W. H., The effect of supplementary choline, methionine and cystine and of casein, lactoalbumin, fibrin, edestin and gelatin in the hemorrhagic degeneration in young rats. J. Nutr. 1941, 21, 291- 305.
25. Handler, P., Bemheim, F., Choline deficiency in the hamster. Proc. Soc. Exp. Med. 1949, 72, 569- 571.
26. Hoffbauer, F. W., Zaki, F. G., Choline deficiency in the baboon and rat compared. Arch. Path. 1965, 79, 364- 369.
27. Lombardi, B., Pani, P., Schlunk, F. F., Choline-deficiency fatty liver: Impaired release of hepatic triglycerides. J. Lipid Res. 1968, 9, 437- 446.
28. Lombardi, B., Effects of choline deficiency on rat hepatocytes. Fed. Proc. 1971, 30, 139- 142.
29. Yao, Z. M., Vance, D. E., Head group specificity in the requirement of phosphatidylcholine biosynthesis for very low density lipoprotein secretion from cultured hepatocytes. J. Biol. Chem. 1989, 264, 11373- 11380.
30. Yao, Z. M., Vance, D. E., The active synthesis of phosphatidylcholine is required for very low density lipoprotein secretion from rat hepatocytes. J. Biol. Chem. 1988, 263, 2998- 3004.
31. Blusztajn, J. K., Zeisel, S. H., 1, 2-sndiacylglycerol accumulates in choline-deficient liver. A possible mechanism of hepatic carcinogenesis via alteration in protein kinase C activity? FEBS Lett. 1989, 243, 267- 270.
32. Jacobs, R. L., Zhao, Y., Koonen, D. P., Sletten, T. et al., Impaired de novo choline synthesis explains why phosphatidylethanolamine N-methyltransferase-deficient mice are protected from diet-induced obesity. J. Biol. Chem. 2010, 285, 22403- 22413.
33. Best, C. H., Huntsman, M. E., Effect of choline on liver fat of rats in various states of nutrition. J. Physiol. 1935, 83, 255- 274.
34. Cooke, R. F., Silva, D., Caraviello, D. Z., Bertics, S. J. et al., Supplemental choline for prevention and alleviation of fatty liver in dairy cattle. J. Dairy Sci. 2007, 90, 2413- 2418.
35. Watkins, S. M., Zhu, X., Zeisel, S. H., Phosphatidylethanolamine N-methyltransferase activity and dietary choline regulate liver plasma lipid flux and essential fatty acid metabolism in mice. J. Nutr. 2003, 133, 3386- 3391.
36. Daily, J. W., Hongu, N., Mynatt, R. L., Sachan, D. S., Choline supplementation increases tissue concentrations of carnitine and lowers body fat in guinea pigs. J. Nutr. Biochem. 1998, 9, 464- 470.
37. Song, Z. et al., Involvement of AMP-activated protein kinase in beneficial effects of betaine on high-sucrose diet-induced hepatic steatosis. Am. J. Physiol. Gastrointest Liver Physiol. 2007, 293, G894- G902.
38. Wang, Z., Yao, T., Pini, M., Zhou, Z. et al., Betaine im-proved adipose tissue function in mice fed a high-fat diet: A mecha-nism for hepatoprotective effect of betaine in nonalcoholic fatty liver disease. Am. J. Physiol. Gastrointest Liver Physiol. 2010, 298, G634- G642.
39. Kwon, d. Y., Jung, Y. S., Kim, S. J., Park, H. K. et al., Impaired sulfur-amino acid metabolism and oxidative stress in nonalcoholic fatty liver are alleviated by betaine supplementation in rats. J. Nutr. 2009, 139, 63- 68.
40. Barak, A. J., Beckenhauer, H. C., Junnila, M., And Tuma, D. J., Dietary betaine promotes generation of hepatic S-adenosylmethionine and protects the liver from ethanol-induced fatty infiltration. Alcohol Clin. Exp. Res. 1993, 17, 552- 555.
41. Purohit, V., Abdelmalek, M. F., Barve, S., Benevenga, N. J. et al., Role of S-adenosylmethionine, folate, and betaine in the treatment of alcoholic liver disease: Summary of a symposium. Am. J. Clin. Nutr. 2007, 86, 14- 24.
42. Ghyczy, M., Boros, M., Electrophilic methyl groups present in the diet ameliorate pathological states induced by reductive and oxidative stress: A hypothesis. Br. J. Nutr. 2001, 85, 409- 414.
43. Best C. H., Ridout, J. H., Lucas, C. C., Alleviation of dietary cirrhosis with betaine and other lipotropic agents. Can. J. Physiol. Pharmacol. 1969, 47, 73- 79.
44. Raubenheimer, P. J., Nyirenda, M. J., Walker, B. R., A choline deficient diet exacerbates fatty liver but attenuates insulin resistance and glucose intolerance in mice fed a high fat diet. Diabetes 2006, 55, 2015- 2020.
45. Poirier, L. A., Grantham, P. H., Rogers, A. E., The effects of amarginally lipotrope-deficient diet on the hepatic levels of S-adenosylmethionine and on the urinary metabolites of 2-acetylaminofluorene in rats. Cancer Res. 1997, 37, 744- 748.
46. Barak, A. J., Kemmy, R. J., Tuma, D. J., The effect of methotrexate on homocysteine methylating agents in rat liver. Drug Nutr. Interact. 1982, 1, 303- 306.
47. Shivapurkar, N., Poirier, L. A., Tissue levels of S-adenosylmethionine and S-adenosylhomocysteine in rats fed methyl-deficient, amino acid defined diets for one to five weeks. Carcinogenesis 1983, 4, 1051- 1057.
48. Zeisel, S. H., Zola, T., daCosta, K., Pomfret, E. A., Effect of choline deficiency on S-adenosylmethionine and methionine concentrations in rat liver. Biochem. J. 1989, 259, 725- 729.
49. Tsujiuchi, T., Tsutsumi, M., Sasaki, Y., Takahama, M., Konishi, Y., Hypomethylation of CpG sites and c-myc gene overexpression in hepatocellular carcinomas, but not hyperplastic nodules, induced by a choline deficient L-amino acid-defined diet in rats. Jpn. J. Cancer Res. 1999, 90, 909- 913.
50. Wainfan, E., Dizik, M., Stender, M., Christman, J., Rapid appearance of hypomethylated DNA in livers of rats fed cancer promoting, methyl-deficient diets. Cancer Res. 1989, 49, 4094- 4097.
51. Locker, J., Reddy, T. V., Lombardi, B., DNA methylation and hepatocarcinogenesis in rats fed a choline devoid diet. Carcinogenesis 1986, 7, 1309- 1312.
52. Wilson, M. J., Shivapurkar, N., Poirier, L. A., Hypomethylation of hepatic nuclear DNA in rats fed with a carcinogenic methyl-deficient diet. Biochem. J. 1984, 218, 987- 990.
53. Bhave, M. R., Wilson, M. J., Poirier, L. A., c-H-ras and c-K-ras gene hypomethylation in the livers and hepatomas of rats fed methyl-deficient, amino acid-defined diets. Carcinogenesis 1988, 9, 343- 348.
54. Rabinowitch, I. M., Effects of betaine upon the cholesterol and bilirubin contents of blood plasma in diabetes mellitus. Can. Med. Assoc. J. 1936, 4, 637- 641.
55. Lowe, R. C., Alimentary lipemia in young diabetics with evidence of liver damage or dysfunction. Clin. Med. 1939, 24, 943- 950.
56. Buchman, A. L., Dubin, M. D., Moukarzel, A. A. et al., Choline deficiency: A cause of hepatic steatosis during parenteral nutrition that can be reversed with intravenous choline supplementation. Hepatology 1995, 22, 1399- 1403.
57. Fischer, L. M., daCosta, K., Kwock, L., Stewart, P. et al., Sex and menopausal status influence human dietary requirements for the nutrient choline. Am. J. Clin. Nutr. 2007, 85, 1275- 1285.
58. Abdelmalek, M. F., Angulo, P., Jorgensen, R. A., Sylvestre, P. B., Lindor, K. D., Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: Results of a pilot study. Am. J. Gastroenterol. 2001, 96, 2711- 2717.
59. Abdelmalek, M. F., Sanderson, S. O., Angulo, P. et al., Betaine for nonalcoholic fatty liver disease: Results of a randomized placebocontrolled trial. Hepatology 2009, 50, 1818- 1826.
60. Miglio, F., Rovati, L. C., Santoro, A., Setnikar, I., Efficacy and safety of oral betaine glucuronate in non-alcoholic steatohepatitis. A double-blind, randomized, parallel-group, placebo-controlled prospective clinical study. Arzneimittelforschung 2000, 50, 722- 727.
61. Patrick, L., Nonalcoholic fatty liver disease: Relationship to insulin sensitivity and oxidative stress. Treatment approaches using vitamin E, magnesium, and betaine. Altern. Med. Rev. 2002, 7, 276- 291.
62. Tokar, J. L., Berg, C. L., Therapeutic options in nonalcoholic fatty liver disease. Curr. Treat. Options Gastroenterol. 2002, 5, 425- 436.
63. Rosamond, W., Flegal, K., Friday, G. et al., Heart disease and stroke statistics-2007 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007, 115, e69- e171.
64. BIBLIOGRAPHY\l4105 World Health Organization, The Atlas of Heart Disease and Stroke, Health Report, WHO Press, Geneva 2004.
65. Villanova, N., Moscatiello, S., Ramilli, S., Bugianesi, E. et al., Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology 2005, 42, 473- 478.
66. da Costa, K. A., Gaffney, C. E., Fischer, L. M., Zeisel, S. H., Choline deficiency in mice and humans is associated with increased plasma homocysteine concentration after a methionine load. Am. J. Clin. Nutr. 2005, 81, 440- 444.
67. Bosy-Westphal, A., Ruschmeyer, M., Czech, N. et al., Determinants of hyperhomocysteinemia in patients with chronic liver disease and after orthotopic liver transplantation. Am. J. Clin. Nutr. 2003, 77, 1269- 1277.
68. Seshadri, S., Beiser, A., Selhub, J. et al., Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N. Engl. J. Med. 2002, 346, 476- 483.
69. Detopoulou, P., Panagiotakos, D. B., Antonopoulou, S., Pitsavos, C., Stefanadis, C., Dietary choline and betaine intakes in relation to concentrations of inflammatory markers in healthy adults: The ATTICA study. Am. J. Clin. Nutr. 2008, 87, 424- 430.
70. Dalmeijer, G. W., Olthof, M. R., Verhoef, P., Bots, M. L., van der Schouw, Y. T., Prospective study on dietary intakes of folate, betaine, and choline and cardiovascular disease risk in women. Eur. J. Clin. Nutr. 2007, 62, 386- 394.
71. Bidulescu, A., Chambless, L. E., Siega-Riz, A. M., Zeisel, S. H., Heiss, G., Usual choline and betaine dietary intake and incident coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study. BMC Cardiovasc. Disord. 2007, 7, 20.
72. Bidulescu, A., Chambless, L. E., Siega-Riz, A. M., Zeisel, S. H., Heiss, G., Repeatability and measurement error in the assessment of choline and betaine dietary intake: The Atherosclerosis Risk in Communities (ARIC) study. Nutr. J. 2009, 8, 14.
73. Konstantinova, S. V., Tell, G. S., Vollset, S. E., Nygard, O. et al., Divergent associations of plasma choline and betaine with components of metabolic syndrome in middle age and elderly men and women. J. Nutr. 2008, 138, 914- 920.
74. Body, R., Griffith, C. A., Keevil, B. et al., Choline for diagnosis and prognostication of acute coronary syndromes in the Emergency Department. Clin. Chim. Acta 2009, 404, 89- 89.
75. LeLeiko, R. M., Vaccari, C. S., Sola, S. et al., Usefulness of elevations in serum choline and free F2)-isoprostane to predict 30-day cardiovascular outcomes in patients with acute coronary syndrome. Am. J. Cardiol. 2009, 104, 638- 643.
76. Danne, O., Möckel, M., Lueders, C. et al., Prognostic implications of elevated whole blood choline levels in acute coronary syndromes. Am. J. Cardiol. 2003, 91, 1060- 1067.
77. Danne, O., Möckel, M., Choline in acute coronary syndrome: An emerging biomarker with implications for the integrated assessment of plaque vulnerability. Expert Rev. Mol. Diagn. 2010, 10, 159- 171.
78. Dalmeijer, G. W., Olthof, M. R., Verhoef, P., Bots, M. L., van der Schouw, Y. T., Prospective study on dietary intakes of folate, betaine, and choline and cardiovascular disease risk in women. Eur. J. Clin. Nutr. 2008, 62, 386- 394.
79. Wang, Z., Klipfell, E., Bennet, B. J., Koeth, R., Levison, B. et al., Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 2011, 472, 57- 63.
80. Markus, K., Oreste, A., Carlo, S., Heini, M. et al., A modified procedure for the rapid preparation of efficiently transporting vesicles from small intestinal brush border membranes. Their use in investigating some properties of d-glucose and choline transport systems. Biochim. Biophys. Acta (BBA)-Biomembr. 1979, 506, 136- 154.
81. Michel, V., Yuan, Z., Ramsubir, S., Bakovic, M., Choline transport for phospholipid synthesis. Exp. Biol. Med. (Maywood) 2006, 231, 490- 504.
82. Zeisel, S. H., da Costa, K. A., Youssef, M., Hensey, S., Conversion of dietary choline to trimethylamine and dimethylamine in rats: Dose-response relationship. J. Nutr. 1989, 119, 800- 804.
83. Zeisel, S. H., Growdon, F. H., Wurtman, R. J., Magil, S. G., et al. Normal plasma choline responses to ingested lecithin. Neurology 1980, 30, 1226- 1229.
84. FDA Modernization Act (FDAMA) Claims, Nutrient content claims notification for choline-containing foods. Available at: (Accessed Nov 2010).
85. Maher, J., Choline: A nutrient to remember. Dyna. Chir. 2006, 24, 26.
86. NutraIngredients-USA. Solae urges food manufacturers to up products' choline content (2006). Available at: (Accessed Nov 2010).
87. Health Canada. Natural Health Products Ingredients Database: Lecithin. Available at: (Accessed Nov 2010).
88. BioPortfolio. Cystadane (betaine anhydrous for oral solution) (2006). Available at: (Accessed Nov 2010).